These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 7041120)
1. Hydrolysis of human platelet membrane glycoproteins with a Serratia marcescens metalloprotease: effect on response to thrombin and von Willebrand factor. Cooper HA; Bennett WP; White GC; Wagner RH Proc Natl Acad Sci U S A; 1982 Mar; 79(5):1433-7. PubMed ID: 7041120 [TBL] [Abstract][Full Text] [Related]
3. Structure and function of platelet membrane glycoproteins Ib and V. Effects of leukocyte elastase and other proteases on platelets response to von Willebrand factor and thrombin. Wicki AN; Clemetson KJ Eur J Biochem; 1985 Nov; 153(1):1-11. PubMed ID: 2933256 [TBL] [Abstract][Full Text] [Related]
4. von Willebrand factor bound to glycoprotein Ib is cleared from the platelet surface after platelet activation by thrombin. Hourdillé P; Gralnick HR; Heilmann E; Derlon A; Ferrer AM; Vezon G; Nurden AT Blood; 1992 Apr; 79(8):2011-21. PubMed ID: 1562727 [TBL] [Abstract][Full Text] [Related]
5. Contrasting effects of thrombin and the thrombin receptor peptide, SFLLRN, on aggregation and release of 14C-serotonin by human platelets pretreated with chymotrypsin or serratia marcescens protease. Kinlough-Rathbone RL; Perry DW; Packham MA Thromb Haemost; 1995 Jan; 73(1):122-5. PubMed ID: 7740483 [TBL] [Abstract][Full Text] [Related]
6. Differentiation of the two forms of GPIb functioning as receptors for alpha-thrombin and von Willebrand factor: Ca2+ responses of protease-treated human platelets activated with alpha-thrombin and the tethered ligand peptide. Greco NJ; Jones GD; Tandon NN; Kornhauser R; Jackson B; Jamieson GA Biochemistry; 1996 Jan; 35(3):915-21. PubMed ID: 8547273 [TBL] [Abstract][Full Text] [Related]
7. Proteolysis of human fixed, washed platelets by gram-negative bacterial metalloproteases: effect on von Willebrand factor-human platelet interactions. Cooper HA; Bennett WP; Kreger A; Lyerly D; Wagner RH Ann N Y Acad Sci; 1981; 370():179-90. PubMed ID: 6791542 [TBL] [Abstract][Full Text] [Related]
8. Antibodies against platelet membrane glycoproteins. III. Effect on thrombin-and bovine Von Willebrand factor-induced aggregation. Jenkins CS; Clemetson KJ; Ali-Briggs EF Br J Haematol; 1983 Mar; 53(3):491-501. PubMed ID: 6600621 [TBL] [Abstract][Full Text] [Related]
9. Fibrinogen competes with von Willebrand factor for binding to the glycoprotein IIb/IIIa complex when platelets are stimulated with thrombin. Gralnick HR; Williams SB; Coller BS Blood; 1984 Oct; 64(4):797-800. PubMed ID: 6236859 [TBL] [Abstract][Full Text] [Related]
10. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Coller BS; Peerschke EI; Scudder LE; Sullivan CA Blood; 1983 Jan; 61(1):99-110. PubMed ID: 6336654 [TBL] [Abstract][Full Text] [Related]
11. Differential response of human and bovine platelets to bovine von Willebrand factor and vascular subendothelium. Rao GH; Escolar G; White JR; Weiss DJ; Burris S; Ordinas A; White JG Platelets; 2001 May; 12(3):150-5. PubMed ID: 11304416 [TBL] [Abstract][Full Text] [Related]
13. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease. Jenkins CS; Phillips DR; Clemetson KJ; Meyer D; Larrieu MJ; Lüscher EF J Clin Invest; 1976 Jan; 57(1):112-24. PubMed ID: 1081991 [TBL] [Abstract][Full Text] [Related]
14. The effect of extracellular proteases from gran-negative bacteria on the interaction of von Willebrand factor with human platelets. Cooper HA; Bennett WP; Kreger A; Lyerly D; Wagner RH J Lab Clin Med; 1981 Mar; 97(3):379-89. PubMed ID: 6780641 [TBL] [Abstract][Full Text] [Related]
15. Differential effect of Serratia protease on platelet surface glycoproteins Ib and V. McGowan EB; Detwiler TC Blood; 1985 Apr; 65(4):1033-5. PubMed ID: 3156641 [TBL] [Abstract][Full Text] [Related]
16. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation. Grainick HR; Williams SB; Coller BS J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor. Danton MC; Zaleski A; Nichols WL; Olson JD J Lab Clin Med; 1994 Aug; 124(2):274-82. PubMed ID: 8051492 [TBL] [Abstract][Full Text] [Related]
18. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells. Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402 [TBL] [Abstract][Full Text] [Related]
19. Agglutination of platelet-type von Willebrand's disease platelets by bovine von Willebrand factor. Takahashi H; Shibata A Thromb Haemost; 1985 Apr; 53(2):204-7. PubMed ID: 2992113 [TBL] [Abstract][Full Text] [Related]
20. The von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments. Handa M; Titani K; Holland LZ; Roberts JR; Ruggeri ZM J Biol Chem; 1986 Sep; 261(27):12579-85. PubMed ID: 2943738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]